Back to results
US 2015/0174092 A1Published application
Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
AssigneeStable Solutions LLC
InventorDavid F. DRISCOLL
Life of this patent
Estimating the term…
Abstract
A method of parenterally administering a composition, the method including parenterally administering to a person a composition including at least one omega-3 fatty acid and at least one drug, wherein the at least one omega-3 fatty acid source and the at least one drug are administered simultaneously.
Claims20
A pharmaceutical composition for parenteral administration comprising at least one omega-3 fatty acid and at least one drug,
- wherein the drug is a Non-Steroidal Anti-Inflammatory Drug selected from the group consisting of acetaminophen, aspirin, ibuprofen, indomethacin, ketorolac as well as the pharmaceutical acceptable salts and derivatives thereof for use in the treatment or prophylaxis of pain or swelling or redness or fever or inflammation, especially for use in treatment or prophylaxis of severe acute post-operative pain,
- wherein the drug is acetaminophen for use in the treatment or prophylaxis of pain and/or fever.
A kit comprising:
- a) one or more container comprising an omega-3-fatty acid component selected from the group consisting of omega-3-fatty acid triglycerides and omega-3-fatty acid ester, such as omega-3 fatty acid ethyl ester;
- and
- b) one or more container comprising at least one drug.
A pharmaceutical system for parenteral administration comprising at least two compartments,
- a) the first compartment comprising an omega-3-fatty acid component selected from the group consisting of omega-3-fatty acid triglycerides and omega-3-fatty acid ester, such as omega-3 fatty acid ethyl ester;
- and
- b) the second compartment comprising at least one drug wherein said omega-3-fatty acid component and said drug are administered simultaneously.
Dependencies are inferred from the claim text.